Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.12
0.08 (1.14%)
At close: Aug 15, 2025, 3:48 PM

Biodexa Pharmaceuticals Balance Sheet Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.67M 5.97M 2.84M 10.06M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a -837K -1.15M
Receivables
715K 704K 329K 33K
Inventory
n/a -704K n/a n/a
Other Current Assets
n/a 704K n/a n/a
Total Current Assets
8.81M 7.03M 4.69M 11.76M
Property-Plant & Equipment
324K 571K 831K 1.15M
Goodwill & Intangibles
5.65M 2.94M 6K n/a
Total Long-Term Assets
5.97M 3.51M 837K 1.15M
Total Assets
14.78M 10.54M 5.53M 12.91M
Account Payables
707K 314K 339K 485K
Deferred Revenue
1.47M n/a 197K n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
921K 4.23M 583K 664K
Total Current Liabilities
5.03M 5.57M 1.9M 1.84M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
1.31M n/a n/a -469
Total Long-Term Liabilities
1.42M 295K 463K 619.53K
Total Liabilities
6.46M 5.86M 2.36M 2.46M
Total Debt
727K 464K 624K 766K
Common Stock
6.69M 1.19M 1.11M 98.47K
Retained Earnings
-150.42M -144.77M -135.34M -127.8M
Comprehensive Income
53M 61.52M 53M 53M
Shareholders Equity
8.32M 4.68M 3.16M 10.45M
Total Investments
n/a n/a n/a n/a